Skip to main content

VLP Therapeutics names seasoned biotech venture capitalist Miwa Toyoda as CBO | National News | kpvi.com

By March 15, 2021News
VLP Therapeutics Logo

VLP Therapeutics Logo

GAITHERSBURG, Md., March 15, 2021 /PRNewswire/ — US-based biotech company VLP Therapeutics, Inc. (VLPT) announced that it has named Ms. Miwa Toyoda, formerly a venture capitalist specialized in pharma and biotech at JAFCO Group Co., Ltd., as chief business officer, effective March 15, in a bid to accelerate its vaccine research and development projects and expand the portfolio.

 

{iframe}https://www.kpvi.com/news/national_news/vlp-therapeutics-names-seasoned-biotech-venture-capitalist-miwa-toyoda-as-cbo/article_2e56a56e-079e-5816-a5d7-0db839075315.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.